 |
 |  |  |  |
CuraGen Announces Expansion of CR011-vcMMAE Phase II Trial in Advanced Breast Cancer
CuraGen Updates CR011-vcMMAE Data at ASCO
| Project | Modality | Indication | Animal Validation | Preclinical | Phase I | Phase Ib | Phase II | Phase III |
| Oncology | ||||||||
| CR011-vcMMAE | Antibody-drug conjugate | Metastatic Melanoma |  | | | |  | |
| Breast Cancer | | | | | | |||
| Brain Tumors | | | ||||||
| CR014-vcMMAE | Antibody-drug conjugate | Ovarian Cancer | | | ||||
| Renal Cell Carcinoma | | | ||||||
Stage definitions: Preclinical - product activity has been shown in animal models and preparations are being made for clinical development; Phase I and beyond - clinical development. The above listed products are investigational. CuraGen has not received marketing approval for any of its products.